Immunotherapy

Open Access
Radiotherapy and Immunotherapy: The Power of the Teamwork for the Treatment of NSCLC
MARIA BASSANELLI, SARA RAMELLA, MASSIMO ZEULI and ANNA CERIBELLI

Anticancer Research May 2022, 42 (5) 2241-2247; DOI: https://doi.org/10.21873/anticanres.15704
Open Access
Chemotherapy Can Synergize With Adoptive Immunotherapy to Inhibit Medulloblastoma Growth
JOSEPH L. LASKY, KATHRYN L. BRADFORD, YUNTAO WANG, YOUNGJU PAK and EDUARD H. PANOSYAN

Anticancer Research April 2022, 42 (4) 1697-1706; DOI: https://doi.org/10.21873/anticanres.15646
You have access
Efficacy of a Flat Low Dose of Nivolumab in Advanced Cancer: A Retrospective Case Series
SOFIE JORIS, CHRISTEL FONTAINE, LORE DECOSTER, JACQUES VANDERAUWERA, KRIS THIELEMANS, WIM WAELPUT and JACQUES DE-GRÈVE

Anticancer Research March 2022, 42 (3) 1433-1437; DOI: https://doi.org/10.21873/anticanres.15613
You have access
Concurrent Nivolumab and Metformin in Diabetic Cancer Patients: Is It Safe and More Active?
CHIARA CICCARESE, ROBERTO IACOVELLI, SEBASTIANO BUTI, FRANCESCA PRIMI, SERENA ASTORE, FRANCESCO MASSARI, MIRIAM GRAZIA FERRARA, GIUSEPPE PALERMO, NAZARIO FOSCHI, VALERIO IACOVELLI, ERNESTO ROSSI, GIOVANNI SCHINZARI, PIERLUIGI BOVE, PIERFRANCESCO BASSI, EMILIO BRIA and GIAMPAOLO TORTORA

Anticancer Research March 2022, 42 (3) 1487-1493; DOI: https://doi.org/10.21873/anticanres.15620
You have access
Characteristics of Human Peripheral Blood γδ T Cells Expanded With Zoledronate
MINSONG KIM, HYORI KIM, MINA HAN, HYUN JU HWANG, HYERY KIM, HO JOON IM, NAYOUNG KIM and KYUNG-NAM KOH

Anticancer Research December 2021, 41 (12) 6031-6038; DOI: https://doi.org/10.21873/anticanres.15422
You have access
A DNA Topoisomerase II Inhibitor Results in Ex Vivo Differentiation of THP-1 Cells and Activation of Dendritic Cells
YOUNG JIN CHO, HEEJAE LEE, JIHYEONG KIM, GYUNGYUB GONG, HEE JIN LEE and IN AH PARK

Anticancer Research December 2021, 41 (12) 6087-6094; DOI: https://doi.org/10.21873/anticanres.15428
You have access
The Role of Immune Checkpoint Inhibitors in Leptomeningeal Disease: A Systematic Review
PAOLO PALMISCIANO, ALI S. HAIDER, CHIBUEZE D. NWAGWU, WASEEM WAHOOD, KENNY YU, CHIBAWANYE I. ENE, BARBARA J. O’BRIEN, SALAH G. AOUN, AARON A. COHEN-GADOL and TAREK Y. EL AHMADIEH

Anticancer Research November 2021, 41 (11) 5333-5342; DOI: https://doi.org/10.21873/anticanres.15346
You have access
SLAMF7 and TREM1 Mediate Immunogenic Cell Death in Colorectal Cancer Cells: Focus on Microsatellite Stability
SEON AE ROH, YI HONG KWON, JONG LYUL LEE, SEON-KYU KIM and JIN CHEON KIM

Anticancer Research November 2021, 41 (11) 5431-5444; DOI: https://doi.org/10.21873/anticanres.15355
You have access
Stereotactic and Hypofractionated Radiotherapy Associated With Immune Checkpoint Inhibitor Drugs: Analysis of Local Control, Toxicity, and Outcome in a Single Research Centre Case Study
DIMITRI ANZELLINI, VITALIANA DE SANCTIS, MAURIZIO VALERIANI, CHIARA REVERBERI, LUCA MARINELLI, MARIA MASSARO, GIANLUCA VULLO, GIUSEPPE FACONDO, RICCARDO CARLO SIGILLO, EMANUELE TOSI and MATTIA FALCHETTO OSTI

Anticancer Research October 2021, 41 (10) 5107-5116; DOI: https://doi.org/10.21873/anticanres.15327
You have access
Intensity-modulated Radiotherapy in Patients With Aggressive Extranodal Non-Hodgkin Lymphoma of the Head and Neck
JENS EISMANN, KHALED ELSAYAD, DANIEL ROLF, IQBAL SARIF, EVA WARDELMANN, HENDRIK BERSSENBRÜGGE, GEORG LENZ and HANS THEODOR EICH

Anticancer Research October 2021, 41 (10) 5131-5135; DOI: https://doi.org/10.21873/anticanres.15330

Main menu

User menu

Search

Immunotherapy

Pages